Necroptosis in Immuno-Oncology and Cancer Immunotherapy

Immune-checkpoint blockers (ICBs) have revolutionized oncology and firmly established the subfield of immuno-oncology. Despite this renaissance, a subset of cancer patients remain unresponsive to ICBs due to widespread immuno-resistance. To “break” cancer cell-driven immuno-resistance, researchers h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprooten, Jenny, De Wijngaert, Pieter, Vanmeerbeek, Isaure, Martin, Shaun, Vangheluwe, Peter, Schlenner, Susan, Krysko, Dmitri V., Parys, Jan B., Bultynck, Geert, Vandenabeele, Peter, Garg, Abhishek D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464343/
https://www.ncbi.nlm.nih.gov/pubmed/32752206
http://dx.doi.org/10.3390/cells9081823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464343/
https://www.ncbi.nlm.nih.gov/pubmed/32752206
http://dx.doi.org/10.3390/cells9081823

Ejemplares similares